Molina Healthcare Inc. is a managed healthcare services provider operating under the Medicaid, Medicare, and state insurance marketplace programs. Founded in 1980, the company serves members across 21 states in the United States. Its business is organized into four reportable segments: Medicaid, Medicare, Marketplace, and Other. The Other segment includes long-term services and supports consultative services in Wisconsin and the commercial portion of the business acquired through the ConnectiCare transaction. The company provides health plans to state and federal customers, focusing on low-cost care delivery and access to services for eligible populations. Molina Healthcare operates as a pure-play government-sponsored healthcare business, competing in high-growth market segments. The company has expanded its footprint through organic growth and acquisitions, including the ConnectiCare deal closed in early 2025. It serves members in programs such as Medicaid, Medicare Advantage, and the Affordable Care Act marketplace.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Healthcare Plans Homepage molinahealthcare.com
Sector Healthcare IR page investors.molinahealthcare.com
Tags
medicaid, medicare, marketplace, managed care, dual-eligible, long-term services and supports, behavioral health, pharmacy, value-based contracting, care management, ConnectiCare
Press page —

Metrics

Valuation  
Market cap $ 11.821B
Market cap (USD) $ 11.821B
P/E -378.88
PEG —
P/BV 2.85
P/S 0.27
P/OCF 35.71
P/FCF 49.67
Dividend yield —
Turnover / mcap —
Returns  
ROE 11.0%
ROI 6.0%
ROIC 8.0%
Profit margin 1.0%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -15.8%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) Yes
Debt/Equity 90.8%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 11
Quality score 11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002
Revenue 45.426B 40.65B 34.072B 31.974B 27.771B 19.423B 16.829B 18.89B 19.883B 17.782B 14.178B 9.667B 6.589B 6.029B 4.77B 3.669B 3.112B 2.492B — — — — —
Net profit 472M 1.179B 1.091B 792M 659M 673M 737M 707M -512M 52M 143M 62.223M 52.929M 9.79M 20.818M 30.868M 62.398M 58.33M 45.727M 27.596M 55.773M 42.517M 30.508M
Free cash flow -636M 544M 1.578B 682M 2.042B 1.816B 370M -344M 718M 497M — — — — — 119.501M 5.741M 136.327M 82.02M 83.298M 80.284M 37.199M 39.52M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002
Share price 173.54 291.05 361.31 330.22 318.08 212.68 135.69 116.22 76.68 54.26 60.13 53.53 34.75 27.06 22.33 23.08 17.01 38.48 33.28 — — — —
Price performance 12m -0.4 -0.19 0.09 0.04 0.5 0.57 0.17 0.52 0.41 -0.1 0.12 0.54 0.28 0.21 -0.2 0.36 -0.56 0.16 — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 974M 871M 1.33B 1.41B 1.67B 2.18B 2.3B 3.1B 3.3B 3.53B
↳ YoY growth +63.1% -10.6% +52.7% +5.7% +18.9% +30.2% +5.7% +34.8% +6.3% +7.1%
↳ 5y CAGR +42.1% +42.2% +34.8% +18.7% +22.9% +17.5% +21.5% +18.5% +18.6% +16.1%
Borrowings, current (USD) 472M 653M 241M 18M 0.00 — — — — —
Borrowings, non-current (USD) 1.17B 1.32B 1.02B 1.24B 2.13B 2.17B 2.18B 2.18B 2.92B 3.77B
Lease liabilities (USD) — — 197M 312M 300M 368M 355M 331M 301M 280M
Cash and deposits (USD) 2.82B 3.19B 2.83B 2.45B 4.15B 4.44B 4.01B 4.85B 4.66B 4.25B
Intangible assets (USD) 140M 69M 47M 29M 249M 270M 275M 208M 267M 237M
Right-of-use assets (USD) — — — 65M 71M 128M — — 35M 30M
Net debt (borrowings + leases - cash) (USD) -1.17B -1.22B -1.57B -885M -1.73B -1.9B -1.48B -2.34B -1.44B -202M
Cash flow detail
Operating cash flow (USD) 673M 804M -314M 427M 1.89B 2.12B 773M 1.66B 644M -535M
Purchases of property, plant and equipment (USD) -176M -86M -30M -57M -74M -77M -91M -84M -100M -101M
Change in receivables (cash effect) (USD) -348M 103M -530M -76M -100M -415M -95M -778M -78M -145M
Change in payables (cash effect) (USD) -4M -12M 45M 2M 78M 138M 55M 328M 115M -221M
Share buybacks (cash effect) (USD) — 0.00 0.00 -47M -606M -128M -400M 0.00 -1B -1B
Interest paid (cash effect) (USD) -66M -78M -93M -78M -112M -127M -108M -108M -121M -181M
Income taxes paid (cash effect) (USD) -153M -7M -240M -239M -321M -235M -340M -405M -379M -275M
Share-based compensation (USD) 26M 46M 27M 39M 57M 72M 103M 115M 116M 47M
Operating cash flow before change in receivables (USD) 1.02B 701M 216M 503M 1.99B 2.53B 868M 2.44B 722M -390M
Free cash flow (OCF - PPE - intangibles) (USD) 497M 718M -344M 370M 1.82B 2.04B 682M 1.58B 544M -636M
Income detail
Total comprehensive income (USD) 54M -515M 705M 749M 706M 617M 637M 1.17B 1.2B 544M
Comprehensive income to owners (USD) 54M -515M 705M 749M 706M 617M 637M 1.17B 1.2B 544M
Reported Mar 1, 2017 Feb 14, 2020 Feb 14, 2020 Feb 14, 2020 Feb 16, 2021 Feb 14, 2022 Feb 13, 2023 Feb 13, 2024 Feb 10, 2026 Feb 10, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Molina Healthcare Inc — Regulation FD Disclosure Bull 0 Bear 0 Guidance

2026 Outlook Affirmation

Members of the senior management team of Molina Healthcare, Inc. (“Molina” or the “Company”) will be participating in UBS’s Global Healthcare Conference on Monday, November 9, 2026. During the conference, and in discussions with investors, the senior management team plans to discuss the Company's business and financial results, including reaffirming the Company’s 2026 full year GAAP diluted earnings per share (EPS) guidance of at least $2.38 and its full year adjusted diluted EPS guidance of at least $5.25. Please refer to the Company’s third quarter 2026 earnings press release attached as Exhibit 99.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 21, 2026 for a reconciliation of full year 2026 adjusted diluted EPS guidance to full year GAAP diluted EPS guidance.

At 10:15 a.m. Eastern Time on November 9, 2026, a simultaneous live audio webcast of Molina’s remarks at UBS’s Global Healthcare Conference 2026 will be available on the Company’s investor relations website, investors.molinahealthcare.com.

Oct 21, 2026

PDF Version

Reaffirms Full Year 2026 Earnings Guidance

LONG BEACH, Calif.--(BUSINESS WIRE)--Oct. 21, 2026-- Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Financial results are summarized below:

| | Three months ended | | Nine months ended |

| | September 30, | | September 30, |

| | 2026 | | 2025 | | 2026 | | 2025 |

| | | | | | | | |

| (In millions, except per-share results) |

| Premium Revenue | $10,457 | | $10,841 | | $30,873 | | $32,337 |

| Total Revenue | $11,082 | | $11,477 | | $32,752 | | $34,051 |

| | | | | | | | |

| GAAP: | | | | | | | |

| Net Income | $38 | | $79 | | $112 | | $632 |

| EPS – Diluted | $0.73 | | $1.51 | | $2.19 | | $11.79 |

| Medical Care Ratio (MCR) | 92.9% | | 92.6% | | 92.1% | | 90.8% |

| G&A Ratio | 6.4% | | 6.4% | | 6.8% | | 6.5% |

| Pre-tax Margin | 0.5% | | 0.8% | | 0.5% | | 2.4% |

| | | | | | | | |

| Adjusted: | | | | | | | |

| Net Income | $46 | | $97 | | $243 | | $724 |

| EPS – Diluted | $0.89 | | $1.84 | | $4.74 | | $13.49 |

| G&A Ratio | 6.3% | | 6.3% | | 6.6% | | 6.4% |

| Pre-tax Margin | 0.6% | | 1.0% | | 1.1% | | 2.7% |

| | | | | | | | |

| See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release. |

Quarter Highlights

  • As of September 30, 2026, the Company served approximately 4.9 million members.

  • Premium revenue was approximately $10.5 billion for the third quarter of 2026.

  • Third quarter 2026 GAAP income per diluted share was $0.73 and adjusted income per diluted share was $0.89.

  • The Company reaffirmed its full year 2026 guidance of expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share.

“We are pleased with our third quarter results in this challenging environment and reaffirm our full year guidance,” said Joseph Zubretsky, President and Chief Executive Officer. “With the apparent plateauing of medical cost trend, which remains at elevated levels, and the strength of recent rate updates for 2027, we believe we are likely observing the beginning of the turn in Medicaid margins.”

Premium Revenue

Premium revenue was approximately $10.5 billion for the third quarter of 2026, a decrease of 4% year over year. The lower premium revenue reflects the impact of lower membership in Medicaid and Marketplace, partially offset by rate updates.

Net Income

GAAP net income for the third quarter of 2026 was $38 million, or $0.73 per diluted share, a decrease of 52% year over year. Adjusted net income for the third quarter of 2026 was $46 million, or $0.89 per diluted share, a decrease of 53% year over year. The decrease is attributed mainly to a higher consolidated MCR.

Medical Care Ratio (MCR)

  • The consolidated MCR for the third quarter of 2026 was 92.9%.

  • The Medicaid MCR for the third quarter of 2026 was 93.0% and in line with the Company’s expectations, reflecting rate updates and stable medical cost trend.

  • The Medicare MCR for the third quarter of 2026 was 93.0% and in line with the Company’s expectations, reflecting stable medical cost trend.

  • The Marketplace MCR for the third quarter of 2026 was 92.5% and in line with normal seasonality and the Company’s expectations.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the third quarter of 2026 were 6.4% and 6.3%, respectively, reflecting continued operating discipline.

Balance Sheet

Cash and investments at the parent company were approximately $608 million as of September 30, 2026, compared to $223 million as of December 31, 2025.

Days in claims payable at September 30, 2026, was 44, consistent with June 30, 2026.

Cash Flow

Operating cash flow for the nine months ended September 30, 2026, was $629 million, compared to an outflow of $237 million for the nine months ended September 30, 2025. The increase compared to the prior year was driven mainly by lower government receivable and payable settlements in 2026.

2026 Guidance

Premium revenue guidance for the full year is unchanged at approximately $42 billion.

The Company expects its full year 2026 GAAP earnings to be at least $2.38 per diluted share and reaffirmed its full year 2026 adjusted earnings of at least $5.25 per diluted share. Guidance metrics across all segments are also reaffirmed. Full year earnings guidance includes a loss of $1.50 per share due to the implementation of the new Florida Medicaid contract in the fourth quarter of 2026 and a loss of $1.00 per share due to performance of the traditional MAPD product, which the Company previously announced it will exit for 2027.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s third quarter ended September 30, 2026 results, at 8:00 a.m. Eastern Time on Thursday, October 22, 2026. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 6534841. A telephonic replay of the conference call will be available through Thursday, October 29, 2026, by dialing (855) 669-9658 and entering confirmation number 4361465. A live audio broadcast of this conference call will be available on Molina Healthcare’s investor relations website, investors.molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “assumes,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding the Company’s 2026 guidance and long-term performance outlook, trends with respect to rates, pretax margins, utilization, and medical costs, including the timing thereof and the anticipated impact on the Company’s business, and our management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Reports on Form 10-Q for the period ended March 31, 2026 and June 30, 2026 filed with the SEC and Quarterly Report on Form 10-Q for the period ended September 30, 2026, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of October 21, 2026, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

| |

| MOLINA HEALTHCARE, INC. |

| UNAUDITED CONSOLIDATED STATEMENTS OF INCOME |

| | | | |

| | Three Months Ended | | Nine Months Ended |

| | September 30, | | September 30, |

| | 2026 | | 2025 | | 2026 | | 2025 |

| | | | | | | | |

| | (In millions, except per-share amounts) |

| Revenue: | | | | | | | |

| Premium revenue | $ | 10,457 | | $ | 10,841 | | $ | 30,873 | | $ | 32,337 |

| Premium tax revenue | | 500 | | | 506 | | | 1,509 | | | 1,325 |

| Investment income | | 102 | | | 108 | | | 301 | | | 322 |

| Other revenue | | 23 | | | 22 | | | 69 | | | 67 |

| Total revenue | | 11,082 | | | 11,477 | | | 32,752 | | | 34,051 |

| Operating expenses: | | | | | | | |

| Medical care costs | | 9,719 | | | 10,044 | | | 28,429 | | | 29,352 |

| General and administrative expenses | | 710 | | | 729 | | | 2,213 | | | 2,214 |

| Premium tax expenses | | 500 | | | 506 | | | 1,509 | | | 1,325 |

| Depreciation and amortization | | 38 | | | 45 | | | 117 | | | 151 |

| Impairment | | — | | | — | | | 93 | | | — |

| Other | | 9 | | | 16 | | | 57 | | | 66 |

| Total operating expenses | | 10,976 | | | 11,340 | | | 32,418 | | | 33,108 |

| Operating income | | 106 | | | 137 | | | 334 | | | 943 |

| Interest expense | | 53 | | | 49 | | | 161 | | | 140 |

| Income before income tax expense | | 53 | | | 88 | | | 173 | | | 803 |

| Income tax expense | | 15 | | | 9 | | | 61 | | | 171 |

| Net income | $ | 38 | | $ | 79 | | $ | 112 | | $ | 632 |

| | | | | | | | |

| Net income per share – Diluted | $ | 0.73 | | $ | 1.51 | | $ | 2.19 | | $ | 11.79 |

| | | | | | | | |

| Diluted weighted average shares outstanding | | 51.5 | | | 52.5 | | | 51.3 | | | 53.6 |

| | | | | | | | | | | | |

| |

| MOLINA HEALTHCARE, INC. |

| CONSOLIDATED BALANCE SHEETS |

| | | | |

| | September 30, | | December 31, |

| | 2026 | | 2025 |

| | Unaudited | | |

| | (Dollars in millions, except per-share amounts) |

| ASSETS |

| Current assets: | | | |

| Cash and cash equivalents | $ | 4,479 | | | $ | 4,248 |

| Investments | | 4,100 | | | | 4,008 |

| Receivables | | 3,359 | | | | 3,533 |

| Prepaid expenses and other current assets | | 576 | | | | 655 |

| Total current assets | | 12,514 | | | | 12,444 |

| Property, equipment, and capitalized software, net | | 324 | | | | 301 |

| Goodwill and intangible assets, net | | 2,073 | | | | 2,195 |

| Restricted investments | | 345 | | | | 299 |

| Deferred income taxes, net | | 267 | | | | 178 |

| Other assets | | 129 | | | | 147 |

| Total assets | $ | 15,652 | | | $ | 15,564 |

| | | | |

| LIABILITIES AND STOCKHOLDERS’ EQUITY |

| Current liabilities: | | | |

| Medical claims and benefits payable | $ | 4,988 | | | $ | 4,887 |

| Amounts due government agencies | | 1,141 | | | | 1,326 |

| Accounts payable, accrued liabilities and other | | 1,183 | | | | 1,093 |

| Deferred revenue | | 82 | | | | 66 |

| Total current liabilities | | 7,394 | | | | 7,372 |

| Long-term debt | | 3,771 | | | | 3,766 |

| Finance lease liabilities | | 179 | | | | 184 |

| Other long-term liabilities | | 153 | | | | 173 |

| Total liabilities | | 11,497 | | | | 11,495 |

| Stockholders’ equity: | | | |

| Common stock, $0.001 par value, 150 million shares authorized; outstanding: 52 million shares at September 30, 2026, and 51 million at December 31, 2025 | | — | | | | — |

| Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding | | — | | | | — |

| Additional paid-in capital | | 536 | | | | 452 |

| Accumulated other comprehensive (loss) income | | (95 | ) | | | 15 |

| Retained earnings | | 3,714 | | | | 3,602 |

| Total stockholders’ equity | | 4,155 | | | | 4,069 |

| Total liabilities and stockholders’ equity | $ | 15,652 | | | $ | 15,564 |

| | | | |

| |

| MOLINA HEALTHCARE, INC. |

| UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS |

| | |

| | Nine Months Ended |

| | September 30, |

| | 2026 | | 2025 |

| | | | |

| | (In millions) |

| Operating activities: | | | |

| Net income | $ | 112 | | | $ | 632 | |

| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | | | |

| Depreciation and amortization | | 117 | | | | 151 | |

| Deferred income taxes | | (54 | ) | | | 37 | |

| Share-based compensation | | 85 | | | | 27 | |

| Impairment | | 93 | | | | — | |

| Other, net | | (21 | ) | | | (2 | ) |

| Changes in operating assets and liabilities: | | | |

| Receivables | | 174 | | | | (118 | ) |

| Prepaid expenses and other current assets | | 11 | | | | (25 | ) |

| Medical claims and benefits payable | | 101 | | | | (157 | ) |

| Amounts due government agencies | | (185 | ) | | | (467 | ) |

| Accounts payable, accrued liabilities and other | | 88 | | | | (195 | ) |

| Deferred revenue | | 16 | | | | (44 | ) |

| Income taxes | | 92 | | | | (76 | ) |

| Net cash provided by (used in) operating activities | | 629 | | | | (237 | ) |

| Investing activities: | | | |

| Purchases of investments | | (1,245 | ) | | | (607 | ) |

| Proceeds from sales and maturities of investments | | 1,020 | | | | 1,017 | |

| Purchases of property, equipment, and capitalized software | | (94 | ) | | | (102 | ) |

| Net cash paid in business combinations | | — | | | | (245 | ) |

| Other, net | | (9 | ) | | | 19 | |

| Net cash (used in) provided by investing activities | | (328 | ) | | | 82 | |

| Financing activities: | | | |

| Proceeds from borrowings under credit facility and term loans | | — | | | | 1,100 | |

| Common stock purchases | | — | | | | (1,000 | ) |

| Repayment of credit facility and term loans | | — | | | | (360 | ) |

| Common stock withheld to settle employee tax obligations | | (15 | ) | | | (37 | ) |

| Other, net | | (16 | ) | | | 35 | |

| Net cash used in financing activities | | (31 | ) | | | (262 | ) |

| Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | | 270 | | | | (417 | ) |

| Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | | 4,348 | | | | 4,741 | |

| Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 4,618 | | | $ | 4,324 | |

| | | | |

| |

| MOLINA HEALTHCARE, INC. |

| UNAUDITED SEGMENT DATA |

| (Dollars in millions) |

| | | | | | | |

| | | September 30, | | December 31, | | September 30, |

| | | 2026 | | 2025 | | 2025 |

| Ending Membership by Segment: | | | | | |

| Medicaid | 4,372,000 | | 4,568,000 | | 4,639,000 |

| Medicare | 222,000 | | 262,000 | | 266,000 |

| Marketplace | 267,000 | | 655,000 | | 713,000 |

| Other | | 1,000 | | 6,000 | | 10,000 |

| Total | 4,862,000 | | 5,491,000 | | 5,628,000 |

| | | | | | | |

| | Three Months Ended September 30, |

| | 2026 | | 2025 |

| | Premium Revenue | | Medical Margin | | MCR (1) | | Premium Revenue | | Medical Margin | | MCR (1) |

| | | | | | |

| Medicaid | $ | 8,199 | | $ | 577 | | 93.0 | % | | $ | 8,015 | | $ | 639 | | 92.0 | % |

| Medicare | | 1,616 | | | 113 | | 93.0 | | | | 1,610 | | | 103 | | 93.6 | |

| Marketplace | | 642 | | | 48 | | 92.5 | | | | 1,197 | | | 53 | | 95.6 | |

| Other (2) | | — | | | — | | NM | | | | 19 | | | 2 | | NM | |

| Consolidated | $ | 10,457 | | $ | 738 | | 92.9 | % | | $ | 10,841 | | $ | 797 | | 92.6 | % |

| | | | | | | | | | | | |

| | Nine Months Ended September 30, |

| | 2026 | | 2025 |

| | Premium Revenue | | Medical Margin | | MCR (1) | | Premium Revenue | | Medical Margin | | MCR (1) |

| | | | | | |

| Medicaid | $ | 24,175 | | $ | 1,793 | | 92.6 | % | | $ | 24,174 | | $ | 2,127 | | 91.2 | % |

| Medicare | | 4,698 | | | 413 | | 91.2 | | | | 4,686 | | | 436 | | 90.7 | |

| Marketplace | | 1,994 | | | 233 | | 88.3 | | | | 3,401 | | | 411 | | 87.9 | |

| Other (2) | | 6 | | | 5 | | NM | | | | 76 | | | 11 | | NM | |

| Consolidated | $ | 30,873 | | $ | 2,444 | | 92.1 | % | | $ | 32,337 | | $ | 2,985 | | 90.8 | % |

| _____________ | | | | | | | | | | | |

| (1) The MCR represents medical costs as a percentage of premium revenue. |

| (2) The Other MCRs are not meaningful. |

MOLINA HEALTHCARE, INC.CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

| | Nine Months Ended |

| | September 30, |

| | 2026 | | 2025 |

| | | | |

| | Unaudited |

| Medical claims and benefits payable, beginning balance | $ | 4,887 | | | $ | 4,640 | |

| Components of medical care costs related to: | | | |

| Current year | | 28,781 | | | | 29,476 | |

| Prior year | | (352 | ) | | | (124 | ) |

| Total medical care costs | | 28,429 | | | | 29,352 | |

| Payments for medical care costs related to: | | | |

| Current year | | 24,692 | | | | 25,425 | |

| Prior year | | 3,963 | | | | 4,059 | |

| Total paid | | 28,655 | | | | 29,484 | |

| Acquired balances, net of post-acquisition adjustments | | — | | | | 361 | |

| Change in non-risk and other payables | | 327 | | | | (25 | ) |

| Medical claims and benefits payable, ending balance | $ | 4,988 | | | $ | 4,844 | |

| | | | |

| Days in Claims Payable (1) | | 44 | | | | 46 | |

| _____________ |

| (1) | | The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements. |

| | | |

MOLINA HEALTHCARE, INC.RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Adjustmentsrepresent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, impairments, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

Adjusted net incomerepresents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income per diluted sharerepresents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Adjusted pre-tax margin represents adjusted income before income tax expense, divided by total revenue.

| | Three Months Ended September 30, | | Nine Months Ended September 30, |

| 2026 | | 2025 | | 2026 | | 2025 |

| | Amount | | Per Diluted Share | | Amount | | Per Diluted Share | | Amount | | Per Diluted Share | | Amount | | Per Diluted Share |

| GAAP Net income | $ | 38 | | | $ | 0.73 | | | $ | 79 | | | $ | 1.51 | | | $ | 112 | | | $ | 2.19 | | | $ | 632 | | | $ | 11.79 | |

| Adjustments: | | | | | | | | | | | | | | | |

| Amortization of intangible assets | $ | 10 | | | $ | 0.19 | | | $ | 20 | | | $ | 0.37 | | | $ | 29 | | | $ | 0.56 | | | $ | 73 | | | $ | 1.35 | |

| Acquisition-related expenses (1) | | — | | | | — | | | | 4 | | | | 0.07 | | | | 33 | | | | 0.61 | | | | 46 | | | | 0.86 | |

| Impairment (2) | | — | | | | — | | | | — | | | | — | | | | 93 | | | | 1.82 | | | | — | | | | — | |

| Other (3) | | — | | | | — | | | | (1 | ) | | | (0.01 | ) | | | 21 | | | | 0.44 | | | | 1 | | | | 0.02 | |

| Subtotal, adjustments | | 10 | | | | 0.19 | | | | 23 | | | | 0.43 | | | | 176 | | | | 3.43 | | | | 120 | | | | 2.23 | |

| Income tax effect | | (2 | ) | | | (0.03 | ) | | | (5 | ) | | | (0.10 | ) | | | (45 | ) | | | (0.88 | ) | | | (28 | ) | | | (0.53 | ) |

| Adjustments, net of tax | | 8 | | | | 0.16 | | | | 18 | | | | 0.33 | | | | 131 | | | | 2.55 | | | | 92 | | | | 1.70 | |

| Adjusted net income | $ | 46 | | | $ | 0.89 | | | $ | 97 | | | $ | 1.84 | | | $ | 243 | | | $ | 4.74 | | | $ | 724 | | | $ | 13.49 | |

| _____________ |

| (1) | | Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs. |

| (2) | | This impairment charge results from the Company’s decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare. |

| (3) | | The nine months ended September 30, 2026 primarily includes non-recurring termination benefits, and the nine months ended September 30, 2025 includes non-recurring litigation costs. |

| | | |

| |

| MOLINA HEALTHCARE, INC. |

| RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED) |

| 2026 GUIDANCE |

| | | | |

| | Amount | | Per Diluted Share (2) |

| GAAP Net income | $ | 122 | | | $ | 2.38 | |

| Adjustments: | | | |

| Acquisition-related expenses | | 48 | | | | 0.89 | |

| Amortization of intangible assets | | 36 | | | | 0.70 | |

| Impairment | | 93 | | | | 1.82 | |

| Other | | 21 | | | | 0.44 | |

| Subtotal, adjustments | | 198 | | | | 3.85 | |

| Income tax effect (1) | | (50 | ) | | | (0.98 | ) |

| Adjustments, net of tax | | 148 | | | | 2.87 | |

| Adjusted net income | $ | 270 | | | $ | 5.25 | |

| _____________ |

| (1) | | Income tax effect calculated at the statutory tax rate of approximately 25.5%. |

| (2) | | Computations assume approximately 51.4 million diluted weighted average shares outstanding. |

View source version on businesswire.com: https://www.businesswire.com/news/home/20261021455974/en/

**Investor Contact:**Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-542-1845

Source: Molina Healthcare, Inc.

Print Page

Print Page

Email Alerts

Email Alerts

Contact IR

Sep 02, 2026

PDF Version

LONG BEACH, Calif.--(BUSINESS WIRE)--Sep. 2, 2026-- Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the third quarter ending September 30, 2026, after the market closes on Wednesday, October 21, 2026, and will host a conference call and webcast to discuss the earnings release on Thursday, October 22, 2026, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 6534841. A telephonic replay of the conference call will be available through Thursday, October 29, 2026, by dialing (855) 669-9658 and entering the confirmation number, 4361465.

A live broadcast of Molina Healthcare’s conference call will be available on the Company’s investor relations website, investors.molinahealthcare.com. A 30-day online replay will be available shortly following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit MolinaHealthcare.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260902086025/en/

**Investor Contact:**Jeffrey Geyer, [email protected], 305-317-3012 Media Contact: Caroline Zubieta, [email protected], 562-951-1588

Source: Molina Healthcare, Inc.

Print Page

Print Page

Email Alerts

Email Alerts

Contact IR

Prompts

Molina Healthcare Inc (ticker MOH), listed in United States.

ETFs Holding Molina Healthcare Inc

ETF Weight in ETF Shares Market value As of
SOVF 4.23% 18,894 $ 3.696M Jul 31, 2026
TCV 2.96% 26,565 $ 5.88M Nov 18, 2026
ECML 2.04% 11,071 $ 2.45M Nov 18, 2026
TAX 1.00% 1,281 $ 254.624K Aug 31, 2026
SEIS 0.91% 23,177 $ 5.301M Jun 30, 2026
HWSM 0.86% 104 $ 23.785K Jun 30, 2026
AFMC 0.67% 7,560 $ 1.762M Nov 16, 2026
CGVV 0.63% 5,485 $ 1.278M Nov 16, 2026
FLDZ 0.61% 109 $ 24.928K Jun 30, 2026
BTAL 0.53% 6,578 $ 1.504M Jun 30, 2026
ITAN 0.48% 2,684 $ 593.728K Nov 17, 2026
SIXL 0.43% 4,266 $ 895.22K Nov 12, 2026
TMED 0.41% 416 $ 95.139K Jun 30, 2026
FFLV 0.41% 343 $ 67.098K Jul 31, 2026
DFAT 0.24% 363,326 $ 76.244M Nov 12, 2026
AVIE 0.23% 161 $ 37.527K Nov 16, 2026
JAVA 0.17% 56,108 $ 12.412M Nov 17, 2026
DFAS 0.15% 235,260 $ 49.369M Nov 12, 2026
AVMC 0.13% 2,978 $ 694.142K Nov 16, 2026
VFMO 0.13% 12,128 $ 2.411M Aug 31, 2026
DFSU 0.08% 8,857 $ 1.859M Nov 12, 2026
AVSU 0.06% 1,305 $ 304.182K Nov 16, 2026
IALT 0.06% 21,091 $ 4.916M Nov 16, 2026
DXUV 0.05% 15,570 $ 3.267M Nov 12, 2026
DFAC 0.05% 198,567 $ 41.669M Nov 12, 2026
ENHU 0.04% 17 $ 3,962.53 Nov 16, 2026
DCOR 0.03% 72,045 $ 15.119M Nov 12, 2026
AVLC 0.03% 1,797 $ 418.863K Nov 16, 2026
JSTC 0.03% 326 $ 75.987K Nov 17, 2026
DFAU 0.02% 12,223 $ 2.565M Nov 12, 2026
DFUS 0.02% 16,238 $ 3.408M Nov 12, 2026
DFUV 0.01% 10,353 $ 2.173M Nov 12, 2026
VOXP 0.01% 3 $ 586.86 Jul 31, 2026
MSLC 0.01% 2,060 $ 409.466K Aug 31, 2026
AVUS 0.01% 7,888 $ 1.839M Nov 16, 2026
EBI 0.01% 278 $ 55.258K Aug 31, 2026
DYNF 0.00% 48 $ 11.188K Nov 16, 2026
NTRL short 0.00% -268 $ 0.00 Nov 16, 2026